New Results Reveal Competitive Advantages of VitroGrow™ Stem Cell Culture Media
News Dec 15, 2010
Vitro Diagnostics, Inc. has announced completion of studies comparing its mesenchymal stem cell culture media, VitroGrow™, to major competitors showing distinct performance improvements over competing products.
These new results showed that VitroGrow™ consistently improved mesenchymal stem cell growth, quality, potency and cellular recovery over leading competitors including comparable products sold by InVitrogen, Lonza and Stem Cell Technologies.
Furthermore, VitroGrow™ also exhibits real-time stability that exceeds 1 year while competitors published recommended usage periods are 2 weeks to 4 weeks, thus resulting in substantial cost savings and expanded usage opportunities to VitroGrow™ customers.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019